Management of patients with antiphospholipid antibodies undergoing in vitro fertilization

Journal of Autoimmunity

Volumn 15, Issue 2, 2000, Pages 209-211

  Udoff, Laurence C ^a   Branch, D Ware ^a  

^a Medical Center   (United States)

Author keywords

Antiphospholipid syndrome; Estradiol; In vitro fertilization and embryo transfer; Ovulation induction

Indexed keywords

CLOMIFENE CITRATE; ESTROGEN; FOLLITROPIN; GONADOTROPIN; HEPARIN; HUMAN MENOPAUSAL GONADOTROPIN; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; EMBOLISM; EMBRYO TRANSFER; ESTROGEN SYNTHESIS; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; OVULATION INDUCTION; PRIORITY JOURNAL; THROMBOSIS; TREATMENT PLANNING;

EID: 0033830167     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0416     Document Type: Conference Paper

References (10)

1. Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins
2. Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in vitro fertilization
3. Response of blood coagulation parameters to elevated endogenous 17β estradiol levels induced by human menopausal gonadotropins
4. Von Willebrand factor: An endothelial marker to monitor in vitro fertilization patients with ovarian hyperstimulation syndrome
5. In vitro fertilization. Do short-term changes in estrogen levels produce increased fibrinolysis?
6. The influence of hyperestrogenism during in vitro fertilization on the fibrinolytic mechanism
7. Risk of thromboembolism in relation to an in-vitro fertilization programme: Three case reports
8. Risks of ovulation-induction therapy in systemic lupus erythenatisus
9. Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle
10. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome